We are live on ! Find out more
ALT icon

Altimmune

34 hedge funds and large institutions have $29.6M invested in Altimmune in 2013 Q2 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

410% more call options, than puts

Call options by funds: $418K | Put options by funds: $82K

Holders
34
Holders Change
+34
Holders Change %
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
Reduced
Closed
Calls
$418K
Puts
$82K
Net Calls
+$336K
Net Calls Change
+$336K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$14K +$14.9K +30 New
Citigroup
27
Citigroup
New York
$7K +$6.94K +14 New
Manulife (Manufacturers Life Insurance)
28
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K +$4.46K +9 New
US Bancorp
29
US Bancorp
Minnesota
$3K +$3.47K +7 New
AIG
30
American International Group
New York
$2.07K +$1.98K +4 New
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$2K +$1.49K +3 New
Wells Fargo
32
Wells Fargo
California
$2K +$1.49K +3 New
Barclays
33
Barclays
United Kingdom
$2K +$2.48K +5 New
Goldman Sachs
34
Goldman Sachs
New York
$1K +$496 +1 New

ALT Hedge Fund Activity: Q2 2013 in Review

34 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2013, worth a combined $29.6M.

Buyers outnumbered sellers: 34 funds opened new ALT positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

  • 34 institutional investors held Altimmune (ALT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $29.6M of Altimmune stock for Q2 2013.
  • 34 funds opened new Altimmune positions in Q2 2013 and 0 closed out, a net change of +34 holders.

Based on aggregated 13F filings for Q2 2013.